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Royal Hospital Haslav cOMPAI<ATIVE AUDIT in which participants submit data into a pooled database and compare their performance with their peers, as with any other audit methodology, should use pre-determined standards to measure against. Frequently comparative audit tends to use its own internal findings to provide the standards. Comparative audit seeks to improve effectiveness but has two potential benefits over data that is not pooled from many participants: the early identification of rare events, particularly adverse outcomes, especially when new treatments are introduced; and it can identify variance between clinicians or hospitals. The potential for comparative audit to identify unexpected adverse outconies does not get the attention it deserves. Research niethodology is ideal for advancing knowledge as it concentrates on defining the efficacy of a treatment, i.e. what can be achieved. The population studied in a research protocol is, however, often small and frequently well defined. Thus this population may not be representative of real life and in particular may not demonstrate rare events that only come to light when a treatment is introduced to an unselected and larger population. Audit methodology looks at effectiveness, i.e. what is achieved, and can be used to seek such unexpected adverse outconies but this does require large numbers. Comparative audit collects large numbers quickly and thus can be used to monitor the introduction of new treatments.
Variance between individual clinicians and hospitals is a major issue and there is good reason to think considerable health gains could ensue from dealing with a ~ such variance.' There arc, however, dangers in interpreting comparative data. If one takes a group of results in a biological system, there is always going to be a best and a worst individual. The majority of participants in a comparative audit will, however, be little different from the mean, there will probably be a small tail of individuals who appear to do badly and another small tail that seem to do well. O n the face of it, comparative audit appears to offer the opportunity of identifying 'the rogue' and there is a belief that dealing with them will make health care more effective and keep it in budget! The problems are that very few individuals will have results that are statistically outside the mean, and it is very important to have some idea of the case mix of the patients involved.
In any endeavour dealing with numbers and statistics, there must be a discipline to the collection and analysis of the data. This is true of comparative audit too! To date much of comparative audit has been concerned with global data collected retrospectively. Though this has provided some interesting facts on activity and structure, the hope that this approach alone would be of continuing value has diminished with time. The major underlying problem with collecting global data is that the information systems introduced into NHS hospitals have in the main been developed as management systems; they do not provide clinicians with data that have sufficient reliability or relevance.' Until clinical activity is captured directly by information systems this approach has a very limited value.
The biggest variable that has to be taken into account in any comparative audit is the patient. It is clear that before any analysis can take place the case mix of the patients has to be accounted for. There is a requirement for validated case mix adjustment3 and to some extent this has been answered by the use of scoring systems such as Physiological operative severity score for the renumeration of mortality and morbidity (POSSUM).4 This need to adjust for case mix is shown by the fact that where such adjustments are used a substantial change in the relative performance of surgeons occurs. In addition one has to be sure that the relevant outcomes are collected accurately, after all the individual who fails to record the complications will appear to be better than the conscientious note keeper; it is well recognized that the recording of complications is unreliable.6 Fundamentally, however, restricting audit to global data concentrates on 'structure' and 'outcome' and ignores 'process'. This approach is limiting and can only tell whether there is a problem or not, it cannot tell what or where the problem is. The data are out-of-date and the harm done. Also, in order to complete the audit cycle the local hospital has to consider the data to see if they need to change and unless they are one of the rogues there tends to be reassurance that they do not need to change! A more constructive and potentially valuable approach, however, would be to concentrate on the excellent in order to influence the average. The average make up the vast majority and a small improvement in their work can have an influence on a large number of patients and make a real difference. It may be better to ignore the rogue and shift the focus to everyone else. To do that a more focused methodology and discipline is required for comparative audit. The discipline requires that the data are collected on individual patients, the patients should be identified prospectively and a piloted and validated system should be used to abstract the data. The audit should include process and outcome data. Focused audit also requires something to measure against, i.e. standards! Determining the standards requires some degree of consensus and the standards must be clinically relevant and scientifically valid. This means that the individual criteria against which the audit is conducted have to be evidence-based otherwise individuals are unlikely to accept the relevance of the audit.
Are there examples of this focus to be found? The paper found in this issue 'Confidential Enquiries into Maternal Deaths in the UK 1992-1993: Lessons for Risk Management', refers to an approach which measures against standards developed over the years from this long standing confidential enquiry. The standards are developed from guidelines developed to overcome defined 'sub-standard care'. A similar approach is to use guidelines and develop review criteria from the individual recommendations contained within; used in breast screening this approach has been shown to stimulate improved performance. Other examples can be found in the 'BAS0 Breast Unit Database' sponsored by the British Association of Surpcal Oncology and similarly an audit, close to completion, based on the recently published 'Guidelines for the Management of Colorectal Cancer'. The aim of these audits is to concentrate on specific items of the process of care shown to be of importance and at the same time look at outcomes 5 7 recognised as relevant. This allows the local hospital to audit itself locally using specific criteria and targets, but because the criteria arc developed as a coniparativc audit, the standards measured against have to be nationally agreed forcing local units to measure theniselves against recognized common practice. In this manner the best can stimulate the average to do better and local risk management can use nationally recognized standards.
The hallmarks of this approach are to base the individual criteria on evidence-based statements recommended within a scientifically valid set of guidelines. To achieve this all relevant professional disciplines need to be involved in the guideline development. The guideline development should be evidencelinked and those developing the guidelines should be a national external group not directly the end users of the guidelines. The audit will need to include relevant case mix measures to allow valid comparisons.
Comparative audit tends to be criticized on the grounds that there is incomplete uptake and that this undermines its value because participants may be selfselecting. Participants often point to the difficulties in finding and funding resources to collect the data along with the inadequacies of hospital information systems. Unless some form of compulsion is introduced, full participation is probably unachievable; an alternative approach would be to conduct a study to establish whether the practice of participants is different to non-participants. If there is no difference the results of participants can then be used to stimulate change in the remainder. The other criticism levelled is that the data may be inaccurate and again rather than seeking an ideal of 10096 accuracy, a study to determine the degree of reliability would give greater confidence in the data. Much of the criticism stems from the use of global retrospective data from inadequate information systems. The development of more focused audits as outlined above would probably address these criticisms and are more likely to gain wider acceptance and increased participation.
The future of comparative audit probably lies with the identification of specific and validated audit tools that look at process as well as outcomes and incorporate adjustments for case mix. The audits should concentrate on improving the effectiveness of the average by identi@ing the work of the excellent and leaving the rogue to be dealt with by other means or as happenstance of conducting the audit. Design of the audit needs cooperation with professional groups or associations recognized as having a relevant input to the care of the patient for the problem being audited; i.e. the principles of multidisciplinary clinical audit should be adhered to. Such tools need to use rigorously developed and accepted methodologies which include defined criteria that are assessed for their reliability. The standards the audit measures against should be evidence linked. The aim of the
